A Novel Selective Small-Molecule PI3K Inhibitor Is Effective Against Human Multiple Myeloma in Vitro and in Vivo

Blood Cancer Journal - United States
doi 10.1038/bcj.2013.37
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

COTI-2, a Novel Small Molecule That Is Active Against Multiple Human Cancer Cell Lines in Vitro and in Vivo

Oncotarget
Oncology
2016English

A Novel PI3K Inhibitor PIK-C98 Displays Potent Preclinical Activity Against Multiple Myeloma

Oncotarget
Oncology
2014English

Eg-011 Is a Novel Small Molecule With in Vitro and in Vivo Anti-Tumor Activity Against Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Correction: A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

A Novel Small Inhibitor, LLL12, Targets STAT3 in Non‑small Cell Lung Cancer In�vitro and In�vivo

Oncology Letters
Cancer ResearchOncology
2018English

In Vitro and in Vivo Activity of a New Small-Molecule Inhibitor of HDAC6 in Mantle Cell Lymphoma

Haematologica
Hematology
2018English

Selective Inactivation of a Human Neuronal Silencing Phosphatase by a Small Molecule Inhibitor

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2011English

Sorafenib Has Potent Antitumor Activity Against Multiple Myeloma in Vitro, Ex Vivo, and in Vivo in the 5T33MM Mouse Model

Cancer Research
Cancer ResearchOncology
2012English

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and in Vivo Evidence

Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy